| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 273 |
| 1 | TOCILIZUMAB | 273 |
| 2 | ABATACEPT | 272 |
| 3 | ETANERCEPT | 272 |
| 4 | INFLIXIMAB | 272 |
| 5 | ADALIMUMAB | 271 |
| 6 | SULFASALAZINE | 271 |
| 7 | ANAKINRA | 269 |
| 8 | METHOTREXATE | 257 |
| 9 | PREDNISONE | 257 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 119 | 0.5694 |
| 1 | VACCINIA IMMUNE GLOBULIN (HUMAN) | 1 | 0.0667 |
| 2 | ANAKINRA | 269 | 0.0230 |
| 3 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 106 | 0.0104 |
| 4 | TRIAMCINOLONE ACETONIDE | 106 | 0.0051 |
| 5 | SULFASALAZINE | 271 | 0.0046 |
| 6 | HUMAN IMMUNOGLOBULIN G | 22 | 0.0040 |
| 7 | TOCILIZUMAB | 273 | 0.0034 |
| 8 | ABATACEPT | 272 | 0.0027 |
| 9 | HYDROXYCHLOROQUINE SULFATE | 151 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 287 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 273 |
| 2 | Aminosalicylate [EPC] | 272 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 272 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 269 |
| 5 | Corticosteroid [EPC] | 267 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 257 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 204 |
| 8 | Vitamin B12 [EPC] | 50 |
| 9 | Vitamin C [EPC] | 50 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 269 | 0.0230 |
| 1 | Human Immunoglobulin G [EPC] | 23 | 0.0039 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 273 | 0.0031 |
| 3 | Aminosalicylate [EPC] | 272 | 0.0029 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 272 | 0.0027 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 257 | 0.0008 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 287 | 0.0004 |
| 7 | Corticosteroid [EPC] | 267 | 0.0003 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 204 | 0.0002 |
| 9 | Vitamin D [EPC] | 50 | 0.0002 |